A Royal Visit Highlighting the Future of AI-Enabled RNA Therapeutics.

LinkedIn Post: HRH The Duchess of Edinburgh

We were delighted to welcome The HRH The Duchess of Edinburgh to our laboratories at Stevenage Bioscience Catalyst for a special visit that marked an important moment for our team.

During her time with us, we had the opportunity to share an overview of our work in RNA technologies and our growing pipeline of therapeutic assets. In a focused and engaging discussion, we explored how AI-enabled platforms are transforming the way we discover and develop new medicines—helping to accelerate timelines and improve the precision with which we bring innovative treatments closer to patients.

The conversation also highlighted the broader importance of supporting cutting-edge science within the UK’s life sciences ecosystem. As the pace of innovation continues to increase, the integration of advanced computational approaches with experimental biology is becoming central to delivering the next generation of therapies.

It was a privilege to showcase our work and to contribute to a dialogue around the future of healthcare innovation. Visits like this not only recognise the progress being made but also reinforce the importance of continued collaboration, investment, and ambition across the sector.

We are grateful to everyone who helped make the visit such a success and look forward to building on the momentum it represents.